questionsmedicales.fr
Troubles dus à des produits chimiques
Effets secondaires indésirables des médicaments
Hypersensibilité médicamenteuse
Toxidermies
Toxidermies : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Dermatite
Réaction médicamenteuse
Biopsie cutanée
Tests cutanés
Éruption cutanée
Symptômes systémiques
Antécédents médicaux
Allergie médicamenteuse
Dermatite
Infection cutanée
Symptômes
5
Éruption cutanée
Démangeaisons
Médicaments
Réaction médicamenteuse
Symptômes systémiques
Fièvre
Éruption cutanée
Toxidermie
Prévention
5
Tests allergiques
Allergie médicamenteuse
Allergies
Professionnels de santé
Médicaments en vente libre
Toxidermie
Traitements
5
Antihistaminiques
Démangeaisons
Corticostéroïdes
Inflammation
Dermatologie
Consultation médicale
Soins de la peau
Irritation cutanée
Complications
5
Syndrome de Stevens-Johnson
Complications
Infections
Lésions cutanées
Hospitalisation
Toxidermie
Facteurs de risque
5
Facteurs de risque
Polypharmacie
Maladies chroniques
Susceptibilité
Polypharmacie
Médicaments
Antécédents familiaux
Allergie médicamenteuse
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Toxidermies : Questions médicales les plus fréquentes",
"headline": "Toxidermies : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Toxidermies : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-27",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Toxidermies"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hypersensibilité médicamenteuse",
"url": "https://questionsmedicales.fr/mesh/D004342",
"about": {
"@type": "MedicalCondition",
"name": "Hypersensibilité médicamenteuse",
"code": {
"@type": "MedicalCode",
"code": "D004342",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pustulose exanthématique aigüe généralisée",
"alternateName": "Acute Generalized Exanthematous Pustulosis",
"url": "https://questionsmedicales.fr/mesh/D056150",
"about": {
"@type": "MedicalCondition",
"name": "Pustulose exanthématique aigüe généralisée",
"code": {
"@type": "MedicalCode",
"code": "D056150",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.174"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome d'hypersensibilité médicamenteuse",
"alternateName": "Drug Hypersensitivity Syndrome",
"url": "https://questionsmedicales.fr/mesh/D063926",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome d'hypersensibilité médicamenteuse",
"code": {
"@type": "MedicalCode",
"code": "D063926",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.262"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Érythème noueux",
"alternateName": "Erythema Nodosum",
"url": "https://questionsmedicales.fr/mesh/D004893",
"about": {
"@type": "MedicalCondition",
"name": "Érythème noueux",
"code": {
"@type": "MedicalCode",
"code": "D004893",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome mains-pieds",
"alternateName": "Hand-Foot Syndrome",
"url": "https://questionsmedicales.fr/mesh/D060831",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome mains-pieds",
"code": {
"@type": "MedicalCode",
"code": "D060831",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.587"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Nicolau",
"alternateName": "Nicolau Syndrome",
"url": "https://questionsmedicales.fr/mesh/D065148",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Nicolau",
"code": {
"@type": "MedicalCode",
"code": "D065148",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.693"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie sérique",
"alternateName": "Serum Sickness",
"url": "https://questionsmedicales.fr/mesh/D012713",
"about": {
"@type": "MedicalCondition",
"name": "Maladie sérique",
"code": {
"@type": "MedicalCode",
"code": "D012713",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Stevens-Johnson",
"alternateName": "Stevens-Johnson Syndrome",
"url": "https://questionsmedicales.fr/mesh/D013262",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Stevens-Johnson",
"code": {
"@type": "MedicalCode",
"code": "D013262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100.468.380.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Toxidermies",
"alternateName": "Drug Eruptions",
"code": {
"@type": "MedicalCode",
"code": "D003875",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yu Sawada",
"url": "https://questionsmedicales.fr/author/Yu%20Sawada",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan."
}
},
{
"@type": "Person",
"name": "Natsuko Saito-Sasaki",
"url": "https://questionsmedicales.fr/author/Natsuko%20Saito-Sasaki",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan."
}
},
{
"@type": "Person",
"name": "Teresa Correia",
"url": "https://questionsmedicales.fr/author/Teresa%20Correia",
"affiliation": {
"@type": "Organization",
"name": "Dermatology and Venereology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte EPE, Lisbon, Portugal."
}
},
{
"@type": "Person",
"name": "Paulo Filipe",
"url": "https://questionsmedicales.fr/author/Paulo%20Filipe",
"affiliation": {
"@type": "Organization",
"name": "Dermatology and Venereology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte EPE, Lisbon, Portugal."
}
},
{
"@type": "Person",
"name": "Etsuko Okada",
"url": "https://questionsmedicales.fr/author/Etsuko%20Okada",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Depression circuit adaptation in post-stroke depression.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37201899",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.05.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dissecting the depressed mood criterion in adult depression: The heterogeneity of mood disturbances in major depressive episodes.",
"datePublished": "2022-11-28",
"url": "https://questionsmedicales.fr/article/36455714",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2022.11.047"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rethinking treatment-resistant depression to quasi-tenacious depression.",
"datePublished": "2023-01-12",
"url": "https://questionsmedicales.fr/article/36632817",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1192/j.eurpsy.2022.2353"
}
},
{
"@type": "ScholarlyArticle",
"name": "Viewpoint: Difficult-to-treat depression versus treatment-resistant depression: A new integrative perspective for managing depression.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37680180",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1192/j.eurpsy.2023.2448"
}
},
{
"@type": "ScholarlyArticle",
"name": "Innate depression.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/35998233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1126/scisignal.ade4885"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles dus à des produits chimiques",
"item": "https://questionsmedicales.fr/mesh/D064419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Effets secondaires indésirables des médicaments",
"item": "https://questionsmedicales.fr/mesh/D064420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité médicamenteuse",
"item": "https://questionsmedicales.fr/mesh/D004342"
},
{
"@type": "ListItem",
"position": 5,
"name": "Toxidermies",
"item": "https://questionsmedicales.fr/mesh/D003875"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Toxidermies - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Toxidermies",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Toxidermies",
"description": "Comment diagnostiquer une toxidermie ?\nQuels tests sont utilisés pour confirmer une toxidermie ?\nQuels signes cliniques indiquent une toxidermie ?\nLes antécédents médicaux sont-ils importants ?\nPeut-on confondre une toxidermie avec d'autres affections ?",
"url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Depression#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Toxidermies",
"description": "Quels sont les symptômes courants d'une toxidermie ?\nLes symptômes varient-ils selon le médicament ?\nUne toxidermie peut-elle provoquer des symptômes systémiques ?\nLes éruptions cutanées sont-elles toujours présentes ?\nLes démangeaisons sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Depression#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Toxidermies",
"description": "Comment prévenir les toxidermies ?\nLes tests allergiques sont-ils utiles ?\nFaut-il informer les médecins de ses allergies ?\nLes patients doivent-ils lire les notices des médicaments ?\nLes médicaments en vente libre sont-ils sûrs ?",
"url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Depression#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Toxidermies",
"description": "Quel est le traitement principal d'une toxidermie ?\nDes antihistaminiques sont-ils recommandés ?\nLes corticostéroïdes sont-ils utilisés ?\nFaut-il consulter un dermatologue ?\nLes soins de la peau sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Depression#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Toxidermies",
"description": "Quelles complications peuvent survenir ?\nLes infections peuvent-elles être une complication ?\nUne hospitalisation est-elle parfois nécessaire ?\nLes complications peuvent-elles être évitées ?\nLes séquelles cutanées sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Depression#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Toxidermies",
"description": "Quels sont les facteurs de risque de toxidermie ?\nLes maladies chroniques influencent-elles le risque ?\nLes femmes sont-elles plus à risque ?\nL'utilisation de plusieurs médicaments augmente-t-elle le risque ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Depression#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une toxidermie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'historique médicamenteux du patient."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer une toxidermie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests cutanés ou des biopsies peuvent être réalisés pour confirmer le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une toxidermie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, démangeaisons et parfois des symptômes systémiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux sont-ils importants ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents d'allergies médicamenteuses aident à établir le diagnostic."
}
},
{
"@type": "Question",
"name": "Peut-on confondre une toxidermie avec d'autres affections ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres dermatites ou infections cutanées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une toxidermie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des éruptions cutanées, démangeaisons, et parfois de la fièvre."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le médicament ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction du type de médicament impliqué."
}
},
{
"@type": "Question",
"name": "Une toxidermie peut-elle provoquer des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fièvre, des douleurs articulaires ou des troubles respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les éruptions cutanées sont-elles toujours présentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines toxidermies peuvent ne pas présenter d'éruptions cutanées visibles."
}
},
{
"@type": "Question",
"name": "Les démangeaisons sont-elles fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les démangeaisons sont un symptôme courant dans de nombreuses toxidermies."
}
},
{
"@type": "Question",
"name": "Comment prévenir les toxidermies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les médicaments connus pour provoquer des réactions cutanées est essentiel."
}
},
{
"@type": "Question",
"name": "Les tests allergiques sont-ils utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests allergiques peuvent aider à identifier les médicaments à éviter."
}
},
{
"@type": "Question",
"name": "Faut-il informer les médecins de ses allergies ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, toujours informer les professionnels de santé de ses allergies médicamenteuses."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils lire les notices des médicaments ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, lire les notices peut aider à identifier les risques d'éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les médicaments en vente libre sont-ils sûrs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certains médicaments en vente libre peuvent aussi provoquer des toxidermies."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal d'une toxidermie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste principalement à arrêter le médicament responsable et à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Des antihistaminiques sont-ils recommandés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antihistaminiques peuvent aider à soulager les démangeaisons et l'inconfort."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils utilisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des corticostéroïdes topiques ou systémiques peuvent être prescrits pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Faut-il consulter un dermatologue ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une consultation dermatologique est souvent nécessaire pour un traitement approprié."
}
},
{
"@type": "Question",
"name": "Les soins de la peau sont-ils importants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins doux de la peau peuvent aider à apaiser les irritations cutanées."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications graves comme le syndrome de Stevens-Johnson peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections secondaires peuvent survenir en raison de lésions cutanées."
}
},
{
"@type": "Question",
"name": "Une hospitalisation est-elle parfois nécessaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hospitalisation peut être nécessaire pour des cas graves de toxidermie."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et approprié."
}
},
{
"@type": "Question",
"name": "Les séquelles cutanées sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles cutanées comme des cicatrices peuvent survenir après une toxidermie."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de toxidermie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies, l'âge avancé et la polypharmacie augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies chroniques peuvent augmenter la susceptibilité aux toxidermies."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les femmes peuvent être plus susceptibles aux toxidermies."
}
},
{
"@type": "Question",
"name": "L'utilisation de plusieurs médicaments augmente-t-elle le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la prise de plusieurs médicaments simultanément augmente le risque d'éruptions."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'allergies médicamenteuses peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan.
Publications dans "Toxidermies" :
4 publications dans cette catégorie
Affiliations :
Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Dermatology and Venereology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte EPE, Lisbon, Portugal.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Dermatology and Venereology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte EPE, Lisbon, Portugal.
Faculdade de Medicina da Universidade de Lisboa, Dermatology Universitary Clinic, Lisbon, Portugal.
Faculdade de Medicina, Dermatology Research Unit, Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, Portugal.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Dermatology, King Saud Medical City, Riyadh, SAU.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, Maharishi Markandeshwar Institute of Medical Sciences and Research, MMDU Mullana, Ambala, Haryana, India.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Pharmacology, EPS Fattouma Bourguiba, University of Monastir, Monastir, Tunisia.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Pharmacology, EPS Fattouma Bourguiba, University of Monastir, Monastir, Tunisia.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Pharmacology, EPS Fattouma Bourguiba, University of Monastir, Monastir, Tunisia.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Pharmacology, EPS Fattouma Bourguiba, University of Monastir, Monastir, Tunisia.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Pharmacology, EPS Fattouma Bourguiba, University of Monastir, Monastir, Tunisia.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Pharmacology, EPS Fattouma Bourguiba, University of Monastir, Monastir, Tunisia.
Publications dans "Toxidermies" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Department of Pharmacology, EPS Fattouma Bourguiba, University of Monastir, Monastir, Tunisia.
Publications dans "Toxidermies" :
1 publication dans cette catégorie
Affiliations :
Yale School of Medicine, Yale, Connecticut, USA.
Publications dans "Toxidermies" :
1 publication dans cette catégorie
Affiliations :
Private Practice, New York, New York, USA; Private Practice, Westport, Connecticut, USA. Electronic address: Lauren.L.Levy@gmail.com.
Publications dans "Toxidermies" :
1 publication dans cette catégorie
Affiliations :
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA; Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.
Publications dans "Toxidermies" :
1 publication dans cette catégorie
Affiliations :
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA; University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Publications dans "Toxidermies" :
Lesion locations of post-stroke depression (PSD) mapped to a depression circuit which centered by the left dorsolateral prefrontal cortex (DLPFC). However, it remains unknown whether the compensatory ...
Rs-fMRI data were collected from 82 non-depressed stroke patients (Stroke), 39 PSD patients and 74 healthy controls (HC). We tested the existence of depression circuit, examined PSD-related alteration...
We found that: 1) the left DLPFC showed significantly stronger connectivity to lesions of PSD than Stroke group; 2) in comparison to both Stroke and HC groups, PSD exhibited increased connectivity wit...
Longitudinal studies are required to explore the alterations of depression circuit in PSD as the disease progress....
PSD underwent specific alterations in depression circuit, which may help to establish objective imaging markers for early diagnosis and interventions of the disease....
Mood disturbances have historically remained a core criterion in diagnosing major depressive episode. DSMs have illustrated this criterion with depressed, hopeless, discouraged, cheerless, and irritab...
The current study used a nationally representative sample of U.S. adults with unipolar major depressive disorder to study the association between specific forms of mood disturbances to depression seve...
Cheerless and hopeless mood were associated with depression severity. Hopeless and irritable mood were associated with depression chronicity. Different forms of mood disturbance showed differential re...
The relations between different forms of mood disturbances and various aspects of depression are nuanced. Theoretically, these relations highlight the potential utility in acknowledging the complexity...
With almost one-third of patients with major depression not adequately responsive to treatments, the management of treatment-resistant depression (TRD) has continued to be challenging. Recently, an es...
In the STAR*D study, the efficacy of treatments for major depression was examined. It was found that, while many responded to the initial antidepressant treatment, only 30% of participants achieved co...
Restoring AHI1 in macrophages may improve antiviral immunity in patients with depression....
Depressive disorders encompass a spectrum of diagnoses and are more common in women and transgender individuals. Diagnosis involves thorough history-taking and exclusion of underlying medical disorder...
To review and summarize the literature published between 1 January 2020 and 30 June 2022, on the prevalence, risk factors and impact of depression in transplant population....
Depression is common in transplantation candidates and recipients, with a prevalence up to 85.8% in kidney recipients. Multiple studies have indicated after transplantation depression correlates with ...
Depression is a common finding in transplant population. More research is needed to understand the biological substrate and risk factors and to develop effective treatment interventions....
The goal of this study was to explore the coping strategies of depression sufferers that have worked for them based on the study of an online depression community....
We conducted a thematic narrative analysis of 120 stories posted by the members in the largest online depression community in China. MaxQDA version 18 was used to code the data, and the analytic appro...
The study found that the coping strategies mainly include self-reconciliation (e.g., perceiving/accepting feelings, accepting the present self, and holding hope for the future), actions (recreational ...
The findings revealed the coping strategies that were helpful and examined how they functioned for the affected members, which make up for the lack of attention to the individual experiences of depres...
Evidence-based treatments for adult depression include psychotherapy and pharmacotherapy, yet little is known about how baseline depression severity moderates treatment outcome....
We aimed to compare the effects of psychotherapy and pharmacotherapy for adult depression and to examine the association between baseline depression severity and treatment outcome, converting multiple...
We conducted systematic searches in bibliographical databases up to September 2022 to identify randomized controlled trials (RCTs) in which psychotherapy was compared with pharmacotherapy in the treat...
We identified 65 RCTs including 7250 participants for the meta-analyses and 56 RCTs including 5548 participants for the meta-regression. We found no significant difference between psychotherapy and ph...
Limitations included the low quality of the included studies, and the omission of long-term effects and within-study variability....
We found no indication for a moderation effect of baseline depression severity on the relative effects of psychotherapy and pharmacotherapy. Thus, other factors such as availability and patients' pref...
Depression is a leading cause of disability, affecting approximately 300 million people globally [...]....